Orthopedic Implants Market by Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others), Biomaterial (Metallic, Ceramic, Polymeric, and Others), and Type (Knee, Hip, Wrist & Shoulder, Dental, Spine, Ankle, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3457
- Pages: 310
-
Format:
The orthopedic implants market accounted for $45,901 million in 2017 is expected to reach $66,636 million by 2025, registering a CAGR of 4.7% from 2018 to 2025.
Orthopedic implants are medical devices that are used to replace or provide support to damaged bones or joints. These are fabricated using stainless steel and titanium alloys for strength, with plastic coating that acts as an artificial cartilage. These implants are applicable in orthopedic injuries, treatment of several types of arthritis, fractures etc. Orthopedic implants also useful in the joint replacement surgery, which is performed to remove the damaged joint and replace it with a new joint, called prosthesis. The remarkable shift from traditional invasive procedures to minimal invasive surgeries has positively impacted the market growth.
Major factors such as rise in prevalence of orthopedic injuries or diseases and rapid increase in the aging population globally drive the market. In addition, technological innovations in the orthopedic implants industry, acceptance for implantable medical devices, and improvement of healthcare infrastructure in the emerging countries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants treatment and stringent government policies hamper the market growth. Furthermore, the emerging economies present lucrative opportunities to the market.
This report segments the orthopedic implants market on the basis of product type, type, material type, and region to provide a detailed assessment of the market. Based on product type, the market is divided into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics and others. On the basis of type, the market is segmented into knee, hip, wrist & shoulder, dental, spine, ankle, and others. Depending on material type, it is differentiated into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. The metallic biomaterials is further segmented into stainless steel, titanium alloy, cobalt alloy, and others.
Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY MARKET BENEFITS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
BY Product Type
o Reconstructive Joint Replacements
Knee Replacement Implants
Hip Replacement Implants
Extremities
o Upper Extremity
Shoulder
Elbow
Wrist
o Lower Extremity
Upper
Lower
o Spinal Implants
Spinal Fusion Devices
Thoracolumbar Devices
Cervical Fixation Devices
Interbody Fusion Devices
Vertebral Compression Fracture (VCF) Devices
Balloon Kyphoplasty Devices
Vertebroplasty Devices
Motion Preservation Devices/Non-Fusion Devices
Dynamic Stabilization Devices
Artificial Disc Replacement Devices
Annulus Repair Devices
Nuclear Disc Prostheses
Invasive Spinal Bone Stimulators
o Dental Implants
Root Form Dental Implants
Plate Form Dental Implants
o Trauma
o Orthobiologics
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others
o Others
By Biomaterial
o Metallic Biomaterials
Stainless steel
Titanium Alloy
Cobalt Alloy
Others
o Polymeric Biomaterials
o Ceramic Biomaterials
o Others
By Type
o Knee
o Hip
o Wrist & Shoulder
o Dental
o Spine
o Ankle
o Others
By Geography
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
o Arthrex, Inc.
o Conmed Corporation
o DJO Finance LLC
o Globus Medical, Inc.
o Johnson & Johnson (DePuy Synthes)
o Medtronic plc.
o Stryker Corporation
o Smith and Nephew plc.
o Wright Medical Group N.V.
o Zimmer Biomet Holdings, Inc.
The other players in the value chain include (profiles not included in the report)
NuVasive, Inc.
Synthes Holding AG
Arthrocare Corporation
Integra Lifesciences Holdings Corporation
Aesculap Implant Systems
The Orthopedic Implant Company
BioTek Instruments, Inc.
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Market share analysis, 2016
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. CLINICAL TRIALS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population
3.5.1.2. Technological advancements in the field of orthopedic implants
3.5.1.3. Global rise in acceptance of orthopedic implants
3.5.1.4. Improved healthcare facilities in developing countries
3.5.2. Restraints
3.5.2.1. High cost of treatment associated with orthopedic implants procedures
3.5.2.2. Stringent approval process as these are highly specialized devices
3.5.3. Opportunities
3.5.3.1. Huge market opportunities in the developing countries
Chapter: 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. RECONSTRUCTIVE JOINT REPLACEMENTS
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Knee replacement implants
4.2.4.1. Market size and forecast
4.2.5. Hip replacement implants
4.2.5.1. Market size and forecast
4.2.6. Extremities
4.2.6.1. Market size and forecast
4.2.6.2. Upper extremity reconstruction
4.2.6.2.1. Market size and forecast
4.2.6.2.2. Shoulder reconstruction
4.2.6.2.2.1. Market size and forecast
4.2.6.2.3. Elbow reconstruction
4.2.6.2.3.1. Market size and forecast
4.2.6.2.4. Hand & wrist
4.2.6.2.4.1. Market size and forecast
4.2.6.3. Lower extremity reconstruction
4.2.6.3.1. Market size and forecast
4.2.6.3.2. Foot reconstruction
4.2.6.3.2.1. Market size and forecast
4.2.6.3.3. Ankle reconstruction
4.2.6.3.3.1. Market size and forecast
4.3. SPINAL IMPLANTS
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Spinal fusion devices
4.3.4.1. Market size and forecast
4.3.4.2. Thoracolumbar devices
4.3.4.2.1. Market size and forecast
4.3.4.3. Cervical fixation devices
4.3.4.3.1. Market size and forecast
4.3.4.4. Interbody fusion devices
4.3.4.4.1. Market size and forecast
4.3.5. Motion preservation devices
4.3.5.1. Market size and forecast
4.3.5.2. Dynamic stabilization devices
4.3.5.2.1. Market size and forecast
4.3.5.3. Artificial discs
4.3.5.3.1. Market size and forecast
4.3.5.4. Annulus repair devices
4.3.5.4.1. Market size and forecast
4.3.5.5. Nuclear disc prostheses
4.3.5.5.1. Market size and forecast
4.3.6. Vertebral compression fracture (vcf) treatment devices
4.3.6.1. Market size and forecast
4.3.6.2. Balloon kyphoplasty devices
4.3.6.2.1. Market size and forecast
4.3.6.3. Vertebroplasty devices
4.3.6.3.1. Market size and forecast
4.3.7. Invasive spinal bone stimulators
4.3.7.1. Market size and forecast
4.4. DENTAL IMPLANTS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Root form dental implants
4.4.4.1. Market size and forecast
4.4.5. Plate form dental implants
4.4.5.1. Market size and forecast
4.5. ORTHOBIOLOGICS
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Allografts
4.5.4.1. Market size and forecast
4.5.4.2. Machined allograft
4.5.4.2.1. Market size and forecast
4.5.4.3. Demineralized bone matrix (dbm)
4.5.4.3.1. Market size and forecast
4.5.5. Bone graft substitutes
4.5.5.1. Market size and forecast
4.5.5.2. Bone morphogenic proteins (bmp)
4.5.5.2.1. Market size and forecast
4.5.5.3. Synthetic bone grafts
4.5.5.3.1. Market size and forecast
4.5.6. Cell based matrices (cbm)
4.5.6.1. Market size and forecast
4.6. TRAUMA & CRANIOMAXILLOFACIAL
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Screw
4.6.4.1. Market size and forecast
4.6.5. Plates
4.6.5.1. Market size and forecast
4.6.6. Staples
4.6.6.1. Market size and forecast
4.6.7. Others
4.6.7.1. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
Chapter: 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CERAMICS BIOMATERIALS
5.2.1. Market size and forecast
5.3. METALLIC BIOMATERIALS
5.3.1. Market size and forecast
5.4. POLYMERIC BIOMATERIALS
5.4.1. Market size and forecast
5.5. NATURAL BIOMATERIALS
5.5.1. Market size and forecast
Chapter: 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast by country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by Biomaterial
6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast by country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by Biomaterial
6.3.5.1. Germany market size and forecast
6.3.5.2. France market size and forecast
6.3.5.3. UK market size and forecast
6.3.5.4. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast by country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by Biomaterial
6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast by country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by Biomaterial
6.5.5.1. Latin America market size and forecast
6.5.5.2. Africa market size and forecast
6.5.5.3. Middle East market size and forecast
Chapter: 7 COMPANY PROFILES
7.1. AESCULAP IMPLANT SYSTEMS
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG (AESCULAP AG)
7.2.1. Company overview
7.2.2. Company Snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. BIOTRONIK SE & CO. KG
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments
7.4. CONMED CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments, 2014-2016
7.6. JOHNSON & JOHNSON
7.6.1. Company overview
7.6.2. Company Snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. STRYKER CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.9.7. Operating Business Segments
7.9.8. Business performance
7.9.9. Key strategic moves and developments
7.10. ZIMMER BIOMET HOLDINGS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
